Novus Biologicals and R&D Systems announce that they will list their catalog of antibodies on BenchSci’s website to increase the amount of published antibody validation data available to researchers. BenchSci is a revolutionary data mining company that uses artificial intelligence and machine learning to gather published antibody usage data from open- and closed-access journals about […]

DANVERS, MA (PRWEB) – Cell Signaling Technology (CST) a leading provider of antibodies, kits, and services, announced that Genentech, a member of the Roche Group, has licensed proprietary PTMScan® technology from CST, further enabling discovery proteomics research. The CST PTMScan technology is an immuno-affinity enrichment method that allows for the discovery of hundreds to thousands of […]

MINNEAPOLIS — Bio-Techne, a global leader of research and manufacturing-grade reagents, has announced a corporate initiative to advance cell and gene therapy research and ex vivo cell processing. Through strategic acquisitions and internal scientific innovation, Bio-Techne has become uniquely positioned to provide a comprehensive, innovative, and flexible set of reagents and instrumentation across the cell and gene […]

Phase II grant to support development of innovative exosome characterization platform BOSTON — NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of $750,000. The program will focus on completing development of the ExoView™ system, the company’s innovative instrument and […]

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimaging probes, known as CPNs™, are set […]

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimaging probes, known as CPNs™, are set […]

BALTIMORE — PathSensors and Ensensor Japan have entered into a partnership to bring novel pathogen detection devices to markets in Japan. Ensensor is a bio-detection company created in joint venture with S.T. Japan, a well-known organization that specializes in selling products such as spectra databases, microscopy accessories, and analytical instruments. The company has become a distributor of PathSensors’ CANARY […]

ST. LOUIS – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc., (LSBio). The Company is a founder-led developer and distributor of antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform. Terms of the […]

Chromatographers now have another tool for analyzing intact mAb’s via reversed-phase: YMC-Triart Bio C4 YMC-Triart Bio C4 was developed specifically for HPLC and UHPLC separations of intact antibodies and other large proteins. This hybrid-silica based butyl phase is especially effective when used for intact antibody analysis at high temperatures and is ideal for high-sensitivity analysis […]

Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market LEXINGTON, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field. The termination of the license […]